MAPT and Alzheimer disease: In line with the clearance hypothesis, PVS burden has been found associated with elevated levels of Aβ and tau [20, 21], vascular Aβ deposition in cerebral amyloid angiopathy [22–24], as well as with clinical diagnosis of mild cognitive impairment (MCI) [25] and AD [26, 27].